A Quiet Revolution in Taiwanese Health Care: Value-Based Payment at KFSYSCC—How One Hospital Proved Doing Right Beats Doing More
As told by Andrew T. Huang, MD, and Chia-Li Lin, MBA
From Complaint to Action
Ask anyone, “What bothers you about the world?” and grievances pour forth. Ask, “How would you fix it?” and the room falls silent. Ask, “Will you start today?” and only a few hands rise. More than thirty years ago Professor Andrew T. Huang raised his hand. He saw the perverse incentives in Taiwan’s fee-for-service system—do more procedures, earn more money, quality unmeasured—and decided to run an experiment inside the hospital he was building from scratch: Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC).
Proving the Problem With Data
Good reform begins with hard numbers. In the early 1990s, while the new hospital was still finding its footing, Dr Huang asked policy-research chief Ling-Ling Yeh to compare recurrence rates among breast-cancer patients treated in major Taiwanese hospitals. Her analysis confirmed what he suspected: outcomes varied wildly. Quality was a postal-code lottery.
Designing a Cure: Value-Based Payment (VBP)
“If you want better care,” Dr Huang insisted, “you must measure quality and tie payment to it.” He charged finance director Chia-Li Lin—working with Lo Ping, Chang Jin-Mei, and Shih Yu-Ping—to calculate the true cost of treating breast cancer at each stage and to bundle those costs into a single fixed price. Eighteen months of chart audits followed. Every chemotherapy drug, every scan, every nursing hour was traced and tallied. The result became the blueprint for Taiwan’s first Value-Based Payment program.
Doing Right, Not Doing More
A guideline was drafted: what tests and treatments a breast-cancer patient should receive at each stage, with room for clinical judgment but no room for waste. The question behind every spreadsheet was simple: How much money is truly reasonable to care for this patient well?
Negotiating With the Government
Next came politics. Dr. Huang met repeatedly with Minister of Health Po-Ya Chang and National Health Insurance (NHI) Director Hung-Jen Chang. The deal: after a patient finished treatment the hospital would receive 80 percent of the bundled fee automatically; the remaining 20 percent would be paid only if KFSYSCC proved the patient had been managed according to protocol and remained free of major preventable complications. The wager raised the pressure but aligned everyone’s interests. In November 2001 the Breast-Cancer VBP Pilot went live at KFSYSCC.
Early Chaos, Lasting Gains
The launch was hectic. The IT department built an entirely new billing platform; finance had to transmit spotless claims; clinicians double-checked every order. Once the dust settled, staff began asking, “Can we reach the same—or better—outcome with fewer resources?”
Nursing introduced peripherally inserted central catheters (PICC), cheaper and easier than surgical ports.
Anesthesiology developed ultrasound-guided paravertebral blocks, letting patients wake faster with fewer side-effects.
Oncology moved short chemotherapy infusions to the outpatient unit, trimming inpatient days and infection risk.
Quality stayed high, costs fell, and the hospital captured the incentive bonus instead of absorbing overruns.
Why VBP Beats Fee-For-Service
Taiwan’s traditional payment model is an open checkbook: the more tests and hospital days, the higher the bill—whether or not patients benefit. VBP flips the script. Think of two restaurants:
In the fee-for-service café you pay for every dish the chef brings, whether you wanted it or not.
In the VBP bistro you agree on a price; the chef must craft a nourishing, satisfying meal within that budget or absorb the loss.
The system rewards quality, penalizes waste, and keeps the overall bill predictable for society.
What Made the Pilot Work
Ms. Lin credits four pillars:
Cross-department teamwork between the breast-cancer clinicians and the administrative offices.
Dedicated case managers who tracked every patient, solved barriers in real time, and supplied outcome data for audits.
A robust breast-cancer registry that turned individual charts into population intelligence.
Fixed salaries for physicians, removing the temptation to pad volumes.
Barriers to Wider Adoption
Why haven’t other hospitals rushed in? The answer is risk. Under VBP, complications eat profits and may even create deficits. Most Taiwanese doctors still earn by the piece; a flat bundle offers no appeal. Implementing VBP also demands data systems and manpower many centers lack. Therefore the KFSYSCC pilot, though renewed and updated whenever NHI revises its fee schedule, remains a rare payment mechanism in Taiwan.
Twenty Years of Proof
Two decades later the program is still running. Dr Huang believes its greatest gift is cultural: “When payment depends on outcomes, surgeons ask nurses how the patient is really doing; pharmacists fine-tune dosing; administrators see quality as revenue protection. Silos break down.”
Ms. Lin adds, “Every time NHI changes prices we pound on the ministry’s door to update the model. That vigilance keeps it alive.”
A Question for Every Reader
If you were ill, would you rather enter a hospital that profits by doing more to you—or one that earns its keep by doing what’s right for you? KFSYSCC has shown that the second choice is not a utopian fantasy. It has cared for patients with evidence-based medicine and remained solvent, for more than twenty years.
“Treat patients with a soft heart; elevate care with hard science; speak to colleagues as you hope they’ll speak to you.”
—Andrew T. Huang